A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.
Clinical trial NCT06232096 · RECRUITING
Trial details
- NCT number
- NCT06232096
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2026-02-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.